CClinicalTrials.gg
TerminatedNCT01933438Updated Nov 17, 2017

Sup-ER Protocol RCT

An interventional study of Sup-ER Protocol and Control in Birth Related Brachial Plexus Injury and Obstetrical Brachial Plexus Palsy, sponsored by University of British Columbia. Terminated at 1 site in Canada. Open to participants aged 6 Weeks to 8 Weeks. Per ClinicalTrials.gov, last updated 2017-11-17.

Sponsored by University of British Columbia · Not applicable, Interventional, and Treatment

Why this study was terminated
The study ended early after encountering logistics challenges and difficulties with site recruitment.
Phase
Not applicable
Study type
Interventional
Enrollment
2
Allocation
Randomized
Ages
6 Weeks to 8 Weeks
Sex
All
01

Study summary

This study evaluates the ability of a supination and external rotation protocol to improve the arm function and anatomy of children with birth related brachial plexus injuries.

Read the detailed description

The brachial plexus is a group of 5 nerves from the spinal cord that provide the movement and sensation of an upper extremity. In some difficult deliveries, traction on the shoulder may lead to damage to the brachial plexus and will result in an arm that is paralyzed. This is called 'birth related brachial plexus injury' (BRBPI). This may occur in up to 1/1000 births and the nerves may be injured minimally to severely. About 2/3 of children with this injury will recover to quite functional levels simply by maintaining looseness of joints while their nerves slowly heal. Some children have nerve injuries severe enough that they require surgical reconstruction with nerve grafts and nerve transfers to achieve even adequate function. Even in children with otherwise "good" recovery, the motions of external rotation of the shoulder and supination of the forearm are weaker, later to recover, and often incomplete. More importantly, lack of full motion leads to long term changes in the structure, growth, and posture of the shoulder requiring further musculoskeletal surgery, or a child with permanent deformity or disability.

Any gains in active and passive range of motion during the first year of life may improve these long-term shoulder outcomes. The investigators have instituted a program of early passive repositioning mostly using a custom Sup-ER (Supination and External Rotation) splint during early growth and development to improve arm position and range of motion where ER and Sup are weak. In compliant patients in a pilot study, the speed and strength of recovery of ER and Supination are improved compared to historical controls. It is a novel splint and protocol designed by the investigators. This study is a randomized controlled trial to evaluate the use of the Sup-ER protocol in multiple centres over a two year period by assessing the arm function at common time points in recovery. The subjects are randomized to the Sup-ER protocol or the currently accepted standard treatment.

02

Conditions studied

  • Birth Related Brachial Plexus Injury
  • Obstetrical Brachial Plexus Palsy

Keywords

  • birth related brachial plexus injury
  • brachial plexus
  • splint
03

In context

Lead sponsor

University of British Columbia is the lead sponsor of 1,309 studies on the registry; 253 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Weeks to 8 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosis of brachial plexus injury at birth.
  • Significant deficit in external rotation and/or supination of the affected limb based on clinical assessment using the Toronto Active Movement Scale at 6 weeks of age (External Rotation ≤ 2 and/or Supination ≤ 2)
  • Tightness in Passive Range of Motion of external rotation: any angle of less than 180°.
  • Age 6-8 weeks

Exclusion criteria

Exclusion Criteria:

  • Neuromuscular disorder
  • Unwillingness or inability to comply with the requirements of the study protocol.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
2 participants (actual)

Study arms

  • Experimental
    Sup-ER protocol

    Early shoulder repositioning (Sup-ER Splint)

    Other: Sup-ER Protocol

  • Active comparator
    Control

    Standard treatment

    Other: Control

Interventions

  • OtherSup-ER Protocol

    Early shoulder repositioning (Sup-ER Splint)

  • OtherControl

    Standard treatment

06

What researchers measure

Primary outcomes

  1. Toronto Active Movement Scale

    Time frame: 1 year of age

07

Study locations

1 site
  • BC Children's Hospital
    Vancouver, British Columbia V6H 3V4, Canada
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 17, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01933438
Lead sponsor
University of British Columbia
Collaborators
Children's & Women's Health Centre of British Columbia
Responsible party
Cynthia Verchere (Principle Investigator, University of British Columbia) — Principal investigator
First posted
Sep 2, 2013
Start date
Jun 2013
Primary completion
May 2014
Completion
May 2014
Last update
Nov 17, 2017

Study contacts

Cynthia Verchere, MD FRCSC
principal investigator · University of British Columbia

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion